Revised SPC: Duavive (oestrogens, conjugated/bazedoxifene acetate) modified release tablets
electronic Medicines Compendium - eMC
electronic Medicines compendium
15 November 2019
The SPC warns of a 2 to 4-fold increase in the risk of gallbladder disease requiring surgery in postmenopausal women receiving oestrogens; patients should therefore be monitored carefully for signs of development of gallbladder disease.